Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article in the Washington Examiner said that when it comes to health insurance, quality matters too. The article cited a study, “The Effects of Antihypertensive Step-Therapy Protocols on Pharmaceutical and Medical Utilization and Expenditures,” published by The American Journal for Managed Care® (AJMC ®) in 2009. The study found that the initial reductions step therapy causes in pharmaceutical costs are overwhelmed by more than $99 per patient in additional emergency room visits and in-patient hospital stays.
An article on Markets Insider Thursday cited a study published by AJMC®. The study, “A Health Plan's Investigation of Healthy Days and Chronic Conditions,” found that patients with six chronic conditions (coronary artery disease, chronic obstructive pulmonary disease, hypertension, diabetes, congestive heart failure, and depression) experienced a greater number of physically and mentally unhealthy days than the population average.
The National Pharmaceutical Council’s Daily Newsfeed e-mail on Thursday highlighted an article published by AJMC®. The article, “VBID Summit Explores How Congress Can Make High-Deductible Plans Work for Consumers,” reported on the healthcare idea, value-based insurance design (VBID). VBID seeks to remove financial barriers to high-value care. The concept of VBID was pioneered by co-editor-in-chief of AJMC® A. Mark Frederick, MD.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More